Home
About
About
Leadership
Scientific Advisory Board
Directors
Disease Focus
Dry Eye Disease
Neuropathic Corneal Pain
Non-infectious Anterior Uveitis
Allergic Conjunctivitis
Technology
Chemerin Receptor
OK-101 Drug Candidate
Preclinical Data
Pipeline
Overview
OK-101 Development Timeline
Investors
Investors
Share Information
Shareholder Services
Investor Presentation
SEC Filings
Corporate Governance
Corporate Documents
Corporate Information
Corporate Directory
FAQs
News
Press releases
Media
Contact
Linkedin
Twitter
Select Page
Hello world!
Mar 20, 2022
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!